Candidates should be strategic and dynamic leaders with experience building and leading commercial marketing functions. A transformational leadership style is required to coach and develop a team of marketers with deep subject matter expertise in key customer audiences, including surgeons, urologist practice staff, and hospital executives. Experience developing integrated marketing plans and commercial programs that drive awareness and adoption is essential. Familiarity with a customer-centric approach and aligning commercial marketing strategies with marketing operations is necessary. Collaboration with marketing and sales leadership to coordinate strategic plans, define goals and KPIs, establish best practices, and create high-impact sales materials is required. Experience partnering with international colleagues to adapt US commercial strategies for global markets is also needed.
The Director, Commercial Marketing will build and lead the Commercial Marketing function, serving as an engine for commercial strategy and driving a customer-centric approach. This role involves developing integrated marketing plans and commercial programs to drive awareness and adoption of Aquablation. Responsibilities include providing vision for commercial marketing strategies, aligning with marketing operations, and defining commercial marketing goals and KPIs. The individual will establish marketing best practice standards and equip commercial teams with impactful sales materials. Key duties involve building a continuum of marketing programs for surgeons, their practices, and hospitals, identifying and quantifying barriers to adoption, and developing targeted programs to address these barriers with compelling messaging and evidence. The role requires aligning with sales leadership on a unified go-to-market strategy, including defining the value proposition and competitive messaging, and collaborating cross-functionally to ensure brand consistency and seamless delivery of content. Furthermore, the Director will provide strategic insights into the annual planning process, partner with international colleagues to adapt US strategies for global markets, and drive program launch excellence initiatives for successful integration of Aquablation into hospitals and practices. Leading urologist practice integration initiatives to build sustainable Aquablation programs is also a core responsibility.
Develops robotic solutions for BPH treatment
PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.